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In mucosa such as tonsil, antibody-producing plasmocytes (PCs) lie in sub-epithelium
space, which is thought to provide a suitable environment for their survival. A proliferation
inducing ligand (APRIL) is one key survival factor for PCs present in this area. According to
in situ staining, apical epithelial cells produced APRIL, and the secreted product had to
migrate all through the stratified surface epithelium to reach basal cells. A similar process
also occurred in the less-organized crypt epithelium. Tonsil epithelial cells captured
secreted APRIL, thanks to their surface expression of the APRIL coreceptor, either
syndecan-1 or -4 depending on their differentiation stage. In the most basal epithelial
cells, secreted APRIL accumulated inside secretory lamp-1+ vesicles in a polarized
manner, facing the sub-epithelium. The tonsil epithelium upregulated APRIL production
by apical cells and secretion by basal cells upon Toll-like receptor stimulation.
Furthermore, LPS-stimulated epithelial cells sustained in vitro PC survival in a secreted
APRIL-dependent manner. Taken together, our study shows that the tonsil epithelium
responds to pathogen sensing by a polarized secretion of APRIL in the sub-epithelial
space, wherein PCs reside.
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INTRODUCTION
A proliferation inducing ligand (APRIL) is one of the last cloned members of the tumor necrosis
factor superfamily (TNFSF13) (1). APRIL has two canonical signaling receptors from the TNF
receptor superfamily, the B-cell maturation antigen (BCMA, TNFRSF18) and the transmembrane
activator and CAML interactor (TACI, TNFRSF13B). These receptors are acquired at specific
differentiation stages after B-cell encounter with their cognate antigens. The latter explains the late
role of APRIL in humoral immunity, mostly in the generation and survival of antibody-producing
plasmocytes (PCs) (2). APRIL is first produced as a transmembrane type II protein, and cleaved
early in the exocytic pathway in the Golgi apparatus by furin proteases (3). As a consequence, full-
length APRIL is not present at the surface of producing cells. Quite unique in the TNFSF, APRIL,
once secreted as a trimer, requires the coreceptor activity of heparan sulfate proteoglycans (HSPG)
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such as syndecan molecules to efficiently signal into target cells
(4, 5). HSPG are proteins containing an O-linked heparan chain
constituted by repeats of the disaccharide unit N-acetyl
glucosamine/glucuronic acid onto which sulfate residues are
added. The ligand specificity of HSPG heavily relies on their
sulfation pattern generated by the maturation action of different
sulfotransferases (6). Specific positioning of negatively charged
sulfate residues on the heparan chain determines the binding
ability to proteins. These proteins must contain a stretch of
positively charged basic residues, such as the one accessible in the
N-terminus of APRIL after furin processing.
Myeloid cells including macrophages, dendritic cells,
eosinophils, and neutrophils are the main cellular source of
APRIL (7). In some cells, i.e., neutrophils and their bone
marrow precursors, APRIL production is constitutive, at least
in part (8, 9). This implies a constant and high steady state level
of APRIL in the bone marrow, an organ known to host long-lived
PCs. This also implies that any neutrophil extravasation will
provide APRIL in an inflamed tissue. Epithelial cells also produce
APRIL (10, 11). Here, we are showing in tonsils that a polarized
secretion of APRIL by apical epithelial cells upon TLR
stimulation occurs across this stratified epithelium to deliver
APRIL to sub-epithelial PCs.
MATERIAL AND METHODS
Human Samples
Samples were obtained at the ORL department of the Grenoble-
Alpes and Geneva University Hospitals from patients with acute
tonsillitis and recurrent tonsillitis associated to infections and
from patients with snoring problems from 2008 to 2015. For the
latter, the patients had not experienced any tonsil infections for
the previous 2 years and had not been treated with antibiotics
during the last 3 months preceding surgery. Patients gave their
informed consent.
Immunohistochemistry
Stalk-1 (rabbit polyclonal) detecting APRIL-producing cells,
Aprily-2 (mouse IgG1) detecting secreted APRI, 10e4 (mouse
IgM, AMS-Bio) detecting native heparan sulfate (HS) chains,
3g10 (mouse IgG2b, AMS-Bio) detecting the HS stub after
heparitinase treatment, and the VSV G tagged ScFv LKiV69
and HS4E4 recognizing N-/2-O sulfates and N- sulfates,
respectively, have been previously described (12–15). Formalin-
fixed paraffin-embedded tonsil sections of 3 µm were stained
with these antibodies. Detection was based on a horseradish
peroxidase–labeled polymer conjugated with secondary
antibodies (EnVision®+, Agilent). Development was done
using 3amino-9-ethyl-carbazol (Sigma-Aldrich), and sections
were counterstained with Mayer’s hematoxylin (Agilent).
Antibodies against syndecan-4 (citrate-based antigen retrieval,
rabbit polyclonal, SC15350, Santa Cruz Biotechnology) and
syndecan-1 (citrate-based antigen retrieval, rabbit polyclonal,
362900, Life Technologies) were used at 10 µg/ml after a heat-
induced epitope retrieval treatment in citrate buffer pH 6. For
58K (clone 58K9, mouse IgG1 Abcam) and lamp-1 (N19, goat
IgG, Santa Cruz Biotechnology), staining was performed on
frozen sections of tonsils. To circumvent the problem of
identical isotype between 58k9 and Aprily-2, the 58K9 staining
was first revealed with a fluorochrome-conjugated anti-mouse
IgG1 followed by the staining of biotinylated Aprily-2 in the
presence of excess of irrelevant mouse IgG1. Alexa-488 and
phycoerythrin-conjugated species/isotype specific secondary
antibodies and streptavidin were all from Life technologies.
DAPI (Agilent) was used for nucleus staining. Peroxidase-
based stainings were visualized with an Axiophot 1, captured
with an Axiocam color CDD camera, and treated on a Pentium
III computer with the AxioVision software, all from Carl Zeiss
AG. For PC numeration, image acquisition was done at the ×40
objective, and syndecan-1-stained cells were counted in the
entire field corresponding to a surface of 30 mm2. For secreted
APRIL signal quantification, images acquired with the 40×
objective were processed with the metamorph image analysis
software (Molecular devices). Color threshold was selected in the
hue saturation intensity space. Saturation values obtained in the
threshold field were added, logged to a spreadsheet, and
expressed in arbitrary unit. Fluorescent costainings were
visualized by confocal microscopy with a LSM510 (Carl Zeiss).
Secreted APRIL/syndecan-4 colocalization was analyzed by using
“RG2B colocalization” plugin for ImageJ. Auto thresholding was
used and pixel intensity acquired with measure tool for processed
and original images. Ratio between the two measures determined
colocalization percentage. Quantification was performed on 90
cells from three independent tonsils.
Flow Cytometry
The 293-T cells were transiently transfected by calcium
phosphate DNA precipitation as previously described (12).
Plasmids encoding for syndecan-1, -2, and -4 were kindly
provided by Dr. Pascal Schneider (University of Lausanne,
Switzerland) (4). Three days after transfection, adherent cells
were harvested with PBS containing 5 mM EDTA and stained
with 10 µg/ml of rabbit polyclonal anti-syndecan-4 and syndecan-1
antibodies. Detection was performed with phycoerythrin-
conjugated goat anti-rabbit antibodies. Fluorescence was
analyzed on a FACSCalibur (BD Biosciences). FACS-sorting of
CD19+ CD38high tonsil plasmocytes was performed as previously
described (10).
Quantitative RT-PCR
Total RNAs were prepared from tonsil samples using Trizol
(Thermo Fisher Scientific), treated with RQ1 DNAse (Promega),
and reverse transcribed with Superscript II reverse transcriptase
and oligo-dT12-18 (Thermo Fisher). Quantitative RT-PCR was
done with a light cycler System (Roche Diagnostics) and the
Quantitect SYBR Green PCR kit solution (Qiagen). For
hAPRIL, 5 ʹ-ATGGGTCAGGTGGTGTCTCG-3 ʹ and 5 ʹ-
ATGGGTCAGGTGGTGTCTCG-3ʹ were used as forward and
reverse primers, respectively. The control GAPDH primers were
5ʹ-TCATGGGTGTGAACCATGAGA-3ʹ (forward) and 5ʹ-
GCTAAGCAGTTGGTGGTGCA-3ʹ (reverse). APRIL cDNA
was used to establish the APRIL standard curve. Total reverse
transcribed RNA from Hela cells was used for the GAPDH
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standard curve. Results were normalized to GAPDH and
expressed as arbitrary units. Amplification was done in
duplicates, and experiments were performed twice.
ELISA
Each tonsil was cut in four slices to perform simulations in
medium alone, 100 ng/ml of LPS (Sigma), 100 ng/ml of LPS with
5 µM actinomycin, and 100 ng/ml of LPS +100 nM tetanus toxin
for 10 h. Tonsils were also stimulated the same way with 10 µg/
ml of peptidoglycan (Sigma). Medium was RPMI-1640 medium
(Gibco) containing 10% fetal calf serum (Eurobio) and penicillin/
streptomycin (Gibco). After stimulation, specific parts of tonsils
separated under a binocular loop were pooled and lyzed in Na
phosphate 0.01 M, EDTA 1 mM, EGTA 1 mM, NaF 1 mM, NaCl
0.15 M pH=7.2, containing 1% Triton X-100, 0.1% NaDOC,
1 mM PMSF, and complete mini cocktail protease inhibitors
from Roche. Protein quantification in lysates was performed
with a BCA protein assay kit (Pierce). To obtain conditioned
supernatants from HaCat cells, seeding was performed at
0,1 10e6 cells/ml, and supernatants were harvested 2 days after
stimulation. APRIL protein concentration was measured with
the APRIL ELISA kit from Bender Medsystems.
In Vitro PC Survival
HaCat cells obtained at the American tissue culture collection
were seeded at a concentration of 0,1 10e6 cells per ml in the
upper compartment of 0,4 µm Transwell plates (Corning), and
stimulated for 2 days with 100 ng/ml of LPS. Then 0,1 10e6
purified tonsil plasmocytes cells were seeded in the bottom
compartment. The blocking antibody to human APRIL
(Mahya-1, mouse IgG1, Adipogen) was used at 10 µg/ml. Live
cells were numerated by trypan blue exclusion.
Statistics
Statistical analysis was performed using GraphPad Prism
software. Normality of data set distribution was tested with the
D’Agostino and Pearson test. Parametric and non-parametric t-
tests were used to compare two data sets with and without,
respectively, normal distributions. For multiple group analysis,
parametric and non-parametric ANOVA tests were run.
Correlation between two data sets were analyzed with the
Pearson’s r coefficient for normally distributed data sets.
Significant differences were defined as p < 0.05. *p < 0.05,
**p < 0.01, ***p < 0.001, ****p < 0.0001.
RESULTS
APRIL Produced by Apical Epithelial Cells
Is Translocated at the Basal Face
In the stratified epithelium from tonsil surface, several layers of
the apical face were reactive with the antibody detecting APRIL-
producing cells (Figure 1A). Notably, processed APRIL
accumulated at distance of its production site in the most basal
layer of this surface epithelium. The crypt epithelium from tonsil
showed a similar expression pattern although less pronounced
between the apical and basal surfaces. Some secreted APRIL was
also detected in the sub-epithelial zone from both areas.
Costaining confirmed the distance between the production and
storage sites for APRIL in the tonsil epithelium (Figure 1B). We
observed a similar expression pattern for APRIL production and
secreted APRIL with other stratified epithelia from mouth skin
(Figure Sup1). In the latter, inflammatory conditions such as
subcutaneous melanoma development were associated to APRIL
production in apical layers and retention of the secreted product
in the basal layer. By contrast, non-inflammatory normal skin
revealed a complete absence of APRIL, indicating an
inflammatory component regulating its production. We
previously observed that the intensity of Stalk-1 staining did
not vary in apical epithelial cells from control and chronically
and acutely infected tonsils (10). Similarly to what we showed in
this latter study for the whole intensity of secreted APRIL, the
intensity for secreted APRIL measured in the sub-epithelial area
from crypts significantly increased from control to chronic and
from chronic to acute tonsils (Figure 1C, upper panels). Notably,
the intensity of secreted APRIL in this sub-epithelial area
correlated with the intensity recorded in the basal face of this
epithelium. In details, the intensity in the basal layer was
significantly higher than in the sub-epithelial area (mean +/−
SD: 1.7 +/− 1,1 vs 0.6 +/− 0,3, p<0,0001, paired parametric t test).
The latter may indicate an accumulation step in basal cells.
Finally, the intensity of secreted APRIL in the sub-epithelial area
correlated with the number of crypt PCs also numerated in this
area. Similar results were obtained when we analyzed all these
parameters for the surface epithelium (Figure 1C, bottom
panels). When the surface and crypt epithelia were compared,
values for secreted APRIL were significantly higher in the crypt,
while PC number was not different (Figure Sup2). Taken
together, this indicates that APRIL, once produced and
processed, migrates from the apical layers to the most basal
layer in the stratified epithelia. Our data also indicate that some
secreted APRIL are delivered to the sub-epithelial area. The
positive correlation found between the density of secreted APRIL
and PC strongly suggests that APRIL plays a survival role for PCs
at that place.
Expression of Heparan Sulfate
Proteoglycan in the Tonsil Epithelium
APRIL is commonly scavenged at the surface of target cells by
HSPG. The surface tonsil epithelium harbored surface HS chain
as revealed in native conditions with the 10e4 antibody. The
10e4 reacted with middle layers of the epithelium but not with
the most basal one (Figure 2A). The 10e4 also stained the
basement membrane between the basal layer and sub-
epithelium. The most basal layer harbored HS of different
nature only stained with the stub-reactive 3g10 antibody. This
basal layer expressed a maturated HS chain reactive with the
other anti-native HS LKiV69 and HS4E4 antibodies (Figure
Sup3). To determine the proteic core of epithelial HSPG, we
used polyclonal antibodies against syndecans. Flow cytometry
on transfected cells demonstrated that these polyclonal
antibodies were member-specific in the syndecan family
Sturm et al. Plasmocyte Survival in Mucosa
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(Figure Sup4). The anti-syndecan-1 stained the surface of
epithelial cells from middle layers but not the extreme basal
layer constituted by less differentiated cells. Costaining showed
that syndecan-1 was 10e4 reactive on epithelial cells from
middle layers. We further identified syndecan-4 on the surface
of basal cells. The anti-syndecan-1 also detected sub-epithelial
PCs harboring a classical eccentric nucleus. Syndecan-1 on
plasmocytes also harbored HS chains as revealed by their
reactivity with 3g10 and to a lesser extent 10e4 (see inserts in
Figure 2). Taken together, this shows that the APRIL-
coreceptor HSPGs are widely expressed by tonsil epithelial
cells with different proteic cores and mature HS chains.
Basal Epithelial Cells Store APRIL in a
Lamp-1+ Compartment
We next wanted to determine the fine localization of secreted
APRIL in the tonsil epithelium. We first noticed that heparitinase
treatment did not significantly diminish secreted APRIL
A B
C
FIGURE 1 | Production and storage sites for APRIL are distant in the tonsil epithelium. (A) Serial sections of tonsils were stained for APRIL production (APRIL p.)
and secreted APRIL (APRIL s.). Scale bar = 10 µm. (B) Costaining for APRIL p. (green) and APRIL s. (red) on the same section is shown. Scale bar = 5 µm. The
epithelium (epi.) and sub-epithelium (sub-epi.) are marked. Results are representative of more than 15 tonsillectomies for patients with chronic infections. (C) Staining
quantification for 15 control, 15 chronically infected, and 15 acutely infected tonsils is shown for secreted APRIL in the sub-epithelial area (left panel). A one-way
unpaired parametric ANOVA test was performed. Correlations with the staining intensity obtained in the basal layer of the epithelium (middle panel) and density of
PCs in the area (right panel) are also shown. A Pearson’s correlation t test was performed. **p < 0.01, ***p < 0.001, ****p < 0.0001.
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reactivity in epithelial cells (Figure 3A). This indicated that
secreted APRIL is predominantly not bound to HSPG.
Costaining experiments confirmed that only a minority of
secreted APRIL detected at the surface of epithelial cells
colocalized with native HS and syndecan-1 (Figure 3B,
arrows). Most of the secreted APRIL resided intracellularly in a
HS, syndecan-1, and syndecan-4 negative compartment both in
middle layers and the most basal layer. Notably, in the syndecan-
4 most basal layer, compartments rich in secreted APRIL
polarized to the basal face. There, we measured a colocalization
of 23,4% +/− 5 between secreted APRIL and syndecan-4. Finally,
use of organelle-specific markers showed that most (70% +/− 15)
secreted APRIL resided in lamp1+ positive cells (Figure 3C). No
secreted APRIL resided in 58K-reactive organelles from the
Golgi apparatus. Accumulation in lamp-1+ vesicles was
particularly evident in basal cells. Taken together, this indicates
that epithelial cells capture APRIL by their surface syndecan, and
APRIL migrates across the different layers of epithelial cells in
intracellular lamp-1+ vesicles. In the basal layer, vesicles rich in
secreted APRIL show a polarized localization towards the sub-
epithelial space.
Toll-Like Receptor Stimulation
Upregulates APRIL Delivery to the
Sub-epithelial Zone to Improve
Plasmocyte Survival
In situ staining right after tonsillectomy never allowed us to
detect full-length APRIL defined by a colocalization in apical
epithelial cells between the reactivity of the antibodies detecting
APRIL-producing cells and secreted APRIL. This indicated a
rapid processing by furin proteases and transport of the
secreted product in adjacent epithelial cells. A short in vitro
stimulation of whole tonsils by LPS allowed us to observe
secreted APRIL reactivity in apical layers in addition to the
accumulation at the basal layer (Figure 4A). In this setting,
unstimulated tonsils kept the APRIL production staining in
apical cells most likely due to the stability of the processed
fragment in producing cells, and showed much less secreted
APRIL accumulation in basal layers. This in vitro short-term
tonsil culture allowed the detection of the APRIL protein by
ELISA with lysed samples of whole tonsils (Figure 4B). We
next performed macroscopic dissection of tonsils to separate
the epithelium from the sub-epithelial zone. Without
A
B
FIGURE 2 | The HSPG syndecan-1 and -4 are expressed by tonsil epithelial cells. (A) Serial sections of tonsils were stained for native HS chain (10e4 reactivity),
the HS stub (3g10 reactivity), and syndecan-1. Scale bar = 10 µm. (B) Tonsil sections were costained for 10e4 (green)/syndecan-1 (red) and syndecan-4 (green)/
syndecan-1 (red). Scale bar = 5 µm. The surface epithelium is shown. In some figures, the epithelium (epi.) and sub-epithelium (sub-epi.) are marked. The arrow and
box show the basement membrane and a plasmocyte, respectively. Results are representative of more than 15 tonsillectomies for patients with recurrent infections.
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stimulation, we only detected weak quantities of APRIL in
fractions containing epithelial cells. LPS stimulation largely
increased APRIL detection in whole and epithelial lysates. In
this condition, the sub-epithelial fraction was also positive.
Notably, use of Actinomycin D to block new transcription
significantly downregulated APRIL concentration in all
samples. Use of tetanus toxin (TT) is known to block
exocytosis (16). TT only diminished APRIL concentration in
sub-epithelial lysates. Similar results were reproduced when
tonsils were stimulated with PGN. Analysis at the mRNA level
by qRT-PCR showed that production was only detected in
samples containing epithelial cells and that this transcription
was upregulated by LPS and PGN stimulation (Figure 4C). We
next used the HaCat keratinocyte cell line as an in vitro model
of epithelial cells. LPS and PGN stimulation upregulated APRIL
transcription and secretion in these cells (Figure 5A). Notably,
APRIL secreted by HaCat cells significantly sustained the in
vitro survival of purified tonsil PC (Figure 5B). Taken together,
these showed that APRIL production in epithelial cells is not
constitutive but dependent of TLR stimulation, at least in part.
Notably, pathogen sensing by TLR from tonsil epithelial cells
upregulated secreted APRIL delivery to induce PC survival.
DISCUSSION
An epithelium formed with tight junctions serves in immunity as
a physical barrier (17). In addition, epithelial cells are active
immune players by the secretion of molecules such as
antimicrobial peptides, chemokines, and cytokines. They also
transport antibodies in a polarized transport-dependent manner
(18). The best-known example of the latter is the basal to apical
transport of IgA taken up from the lamina propria to the lumen
of the intestine. This process is mediated by a specific receptor,
the polymeric IgA receptor. The reversed polarized transport
from apical to basal across an epithelium also occurs. This is the
case for the delivery of maternal IgG to the fetus via the neonatal
Fc receptor. Here, we are showing that an apical to basal
polarized secretion pathway also exists for APRIL. This process
is making a lot of sense, since only apical epithelial cells from a
stratified epithelium with tight junctions may sense pathogens,
and the APRIL target cell, the plasmocyte, is known to reside
beneath the epithelium, in the sub-epithelial area.
Tonsil epithelial cells express at their surface the HSPG
syndecan-1 and syndecan-4. Syndecan-1 is expressed in middle




FIGURE 3 | Processed APRIL accumulates in LAMP-1+ vesicles in the basal layer. (A) Serial sections of tonsils were stained for secreted APRIL in the absence or
presence of heparitinase treatment. Scale bar = 20 µm. Results are representative of three tonsillectomies. (B) Secreted APRIL (red) was costained with syndecan-
1/-4 and native HS (all green). Arrows show colocalization of secreted APRIL with HS/syndecan-1/syndecan-4. Scale bar = 5 µm. Results are representative of 10
tonsillectomies. (C) Secreted APRIL (green) was costained with Golgi (58k, red) and exosome (Lamp-1, green) markers. Scale bar = 10 µm. Surface epithelia are
shown with the apical, basal, and sub-epithelium (sub-epi.) localizations marked. In some experiments, nuclear staining (DAPI) is shown. Patients with recurrent
infections were used. Results are representative of 10 tonsillectomies.
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This demonstrates proteic core variability among HSPG
according to epithelial cell differentiation stage. Another
variability exists at the level of the HS chain maturation. The
3g10 reactivity considered as being close to a pan HSPG was
widely present in middle and basal layers. The 10e4 antibody
recognizes HS chains containing N-unsubstituted glucosamine
(19). The 10e4 reacts only with middle layers but not basal ones.
The latter do possess a mature HS chain stained by the LKIV69
and HS4E4 antibodies, recognizing at least N-/2-O sulfates and
N- sulfates, respectively. These two antibodies also stained
epithelial cells above the most basal layer. Taken together, this
shows the high variable HSPG content at the surface of epithelial
cells, at least in the tonsil epithelium. We did not find evidences
for syndecan/HS surface expression by most apical epithelial cells
very certainly to avoid the recapture of the APRIL they secrete.
Notably, syndecans have already been implicated in the apical to
basal transport in the case of human immunodeficient virus




FIGURE 4 | Tonsil epithelium secretes APRIL in the parenchyma upon TLR stimulation. (A) Serial sections of medium- and LPS-stimulated tonsils were stained for
APRIL production and secreted APRIL. Insert shows a high magnification of a cluster of apical epithelial cells positive for secreted APRIL. A crypt epithelium is
shown. Scale bar = 20 µm. (B) APRIL was quantified by ELISA from the indicated parts of unstimulated, LPS-, and PGN-stimulated tonsils. Actinomycin D (Act.) and
Tetanus toxin (TT) were used to block transcription and exocytosis, respectively. A paired parametric ANOVA test was performed. (C) APRIL mRNA was quantified
by qRT-PCR in the indicated part of unstimulated and LPS/PGN-stimulated tonsils. Results are representative of 10 tonsillectomies. Non-inflamed tonsils removed for
snoring problems were used. Means +/− SD are shown. A paired non-parametric t test was performed. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Sturm et al. Plasmocyte Survival in Mucosa
Frontiers in Immunology | www.frontiersin.org August 2021 | Volume 12 | Article 7157247
secreted APRIL was mainly detected intracellularly in lamp-1+
vesicles devoid of syndecan expression. In fact, APRIL transport
across the tonsil epithelium engages an intracellular route with
lamp-1+ vesicles. Notably, lamp-1 vesicles have already been
implicated in an apical to basal transport in endothelial cells (21).
Hence, it is likely that the polarized secretion of APRIL uses such
a pathway to cross the tonsil epithelium. The predominant
intracellular localization of secreted APRIL observed here in all
the tonsils analyzed does not mean that APRIL transport is
independent of HS and syndecans. Indeed, detection of secreted
APRIL at the surface of epithelial cells bound to HS/syndecan
was possible even though to a much lower extent than its
intracellular localization. Hence, epithelial cells may capture
APRIL on to their surface syndecan before translocating it via
intracellular lamp-1+ vesicles. Our study has some limitations,
since the secretion pathway has been studied in fixed materials in
the absence of any kinetics experiments. We also did not use for
in vitro experiments a stratified epithelium to deeply assess the
cellular pathways implicated in these processes.
Tonsil epithelial cells with the use of cell lines have been
previously shown to respond to TLR ligands (22). Here, we are
showing that production of APRIL by apical epithelial cells from
tonsils is largely upregulated by peptidoglycan, a TLR-2 ligand,
and LPS, a TLR-4 ligand. In addition, TLR stimulation also
increases APRIL secretion in the sub-epithelial zone. We
observed a similar pattern of APRIL expression in other
stratified epithelium such as the mouth and the skin,
indicating that APRIL polarized secretion may occur in
different stratified epithelium, keratinizing or not. Our present
study highlights a translocation process of APRIL produced by
apical cells across both tonsil epithelium, surface and crypt, with
a delivery to the sub-epithelial area. Further investigations are
required to decipher the cellular pathways mediating such
polarized secretion. Owing to the well-characterized
prosurvival role of APRIL for PC, it is very much likely that
this process serves to maintain PCs produced in this secondary
lymphoid organ. Notably, the entire process, from APRIL
production by apical cells to the delivery by basal cells to the
sub-epithelium, is upregulated in the case of an infection.
Hence, PC survival in the tonsil should be largely dependent
on the inflammation status of the organ, a concept that has been
already postulated for PC survival outside the bone
marrow (23).
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FIGURE 5 | TLR-stimulated APRIL production by epithelial cells sustains
plasmocyte survival. (A) HaCat cells were stimulated with LPS and PGN. APRIL
mRNA (left panel) and protein in the cell supernatant (right panel) were
quantified by qRT-PCR and ELISA, respectively, after 48 h. Five independent
experiments were performed. One-way non-parametric (mRNA) and parametric
(protein) ANOVA tests were performed. (B) HaCat cells were seeded in the
upper compartment of a transwell and stimulated with 100 ng/ml of LPS for
48 h. FACS-sorted tonsil PCs were added in the bottom compartment. The %
of PC survival at the indicated time is shown with 100% defined by the initial PC
input. Means +/− SD are shown. An unpaired parametric two-way ANOVA test
was performed. *p < 0.05, **p < 0.01, ****p < 0.0001.
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